InvestorsHub Logo
Followers 1
Posts 357
Boards Moderated 0
Alias Born 03/14/2008

Re: None

Friday, 07/11/2014 7:37:40 AM

Friday, July 11, 2014 7:37:40 AM

Post# of 8566
JPMorgan initiated coverage on Halozyme Therapeutics (NASDAQ: HALO) with an Overweight rating and a price target of $13.00.

For an analyst ratings summary and ratings history on Halozyme Therapeutics click here. For more ratings news on Halozyme Therapeutics click here.

Shares of Halozyme Therapeutics closed at $9.29 yesterday.



Percy
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News